SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • July 27th, 2023 • Alzamend Neuro, Inc. • Pharmaceutical preparations
This Second Amendment is made and entered into on the 17th day of April, 2023 (“Effective Date”), by and between the UNIVERSITY OF SOUTH FLORIDA RESEARCH FOUNDATION, INC. (hereinafter referred to as “Licensor”), a corporation not for profit under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida pursuant to section 1004.28 Florida Statutes, and Alzamend Neuro, Inc., classified as a corporation organized and existing under the laws of Delaware (hereinafter referred to as “Licensee”).
SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • July 27th, 2023 • Alzamend Neuro, Inc. • Pharmaceutical preparations
This Amendment is made and entered into on the 17th day of April, 2023 (“Effective Date”), by and between the UNIVERSITY OF SOUTH FLORIDA RESEARCH FOUNDATION, INC. (hereinafter referred to as “Licensor”), a corporation not for profit under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida pursuant to section 1004.28 Florida Statutes, and Alzamend Neuro, Inc., classified as a corporation organized and existing under the laws of Delaware (hereinafter referred to as “Licensee”).
THIRD AMENDMENT TO LICENSE AGREEMENT Agreement # LIC18110License Agreement • July 27th, 2023 • Alzamend Neuro, Inc. • Pharmaceutical preparations
This Third Amendment is made and entered into on the 8th day of June, 2023 (“Effective Date”), by and between the UNIVERSITY OF SOUTH FLORIDA RESEARCH FOUNDATION, INC. (hereinafter referred to as “Licensor”), a corporation not for profit under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida pursuant to section 1004.28 Florida Statutes, and Alzamend Neuro, Inc., classified as a corporation organized and existing under the laws of Delaware (hereinafter referred to as “Licensee”).
SIXTH AMENDMENT TO LICENSE AGREEMENT Agreement # LIC16118License Agreement • July 27th, 2023 • Alzamend Neuro, Inc. • Pharmaceutical preparations
This Sixth Amendment, is made and entered into on the 17th day of April, 2023 (“Effective Date”), by and between the UNIVERSITY OF SOUTH FLORIDA RESEARCH FOUNDATION, INC. (hereinafter referred to as “Licensor”), a corporation not for profit under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida pursuant to section 1004.28 Florida Statutes, and Alzamend Neuro, Inc., classified as a corporation organized and existing under the laws of Delaware (hereinafter referred to as “Licensee”).
THIRD AMENDMENT TO LICENSE AGREEMENT Agreement # LIC18111License Agreement • July 27th, 2023 • Alzamend Neuro, Inc. • Pharmaceutical preparations
THIS AMENDMENT, is effective, as of the 8th day of June 2023 (Effective Date of this Amendment), by and between the University of South Florida Research Foundation, Inc. (“USFRF”), a nonstock, nonprofit Florida Corporation under Chapter 617 Florida Statutes, and a direct-support organization of the University of South Florida pursuant to Section 1004.28, Florida Statutes (“University”) and Alzamend Neuro, Inc. (“Licensee”), a small corporation organized and existing under the laws of Delaware.
